Advanced SearchNewsfeedFollowed Companies

ICON's Competitors, Revenue, Number of Employees, Funding and Acquisitions

ICON is a contract research firm that provides outsourced development services to the pharmaceutical, biotechnology and ... Read more

Annual Revenue

Employees

Steve Cutler's photo - CEO of ICON

CEO

Steve Cutler

CEO Approval Rating

72/100

OVERVIEW

Founded:

1990

Headquarters:

Leopardstown, County Dublin

Status:

PublicNASDAQICLR

Industry Sector:

Health Care Services

SIC Code:

8000NAICS listing »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is LabCorp a competitor of ICON?

I don't know

Trending News for ICON and ICON's Competitors

May 27, 2020

MarketScreener

ICON plc : to Present at Jefferies Virtual Healthcare Conference

(marketscreener.com) ICON plc, a global provider of drug and device development and commercialisation... See more »

May 28, 2020

BioSpace

Daiichi Sankyo and Syneos Health Form Strategic Coalition for Development of Daiichi Sankyo's ADC Oncology Pipeline

Daiichi Sankyo and Syneos Health ® Form Strategic Coalition for Development of Daiichi Sankyo's ADC O... See more »

May 27, 2020

Zolmax News

Iqvia Holdings Inc (NYSE:IQV) Shares Acquired by State Street Corp

State Street Corp boosted its position in Iqvia Holdings Inc (NYSE:IQV) by 1.9% in the 1st quarter, H... See more »

Competitive Analysis

TOP COMPETITORS OR ALTERNATIVES

IQVIA is ICON's #1 competitor. IQVIA is a Public company that was founded in 1982 in Durham, North Carolina. IQVIA is in the Health Care Technology industry. Compared to ICON, IQVIA has 54,500 more employees.

Parexel is seen as one of ICON's biggest rivals. Parexel was founded in Billerica, Massachusetts} in 1982. Parexel competes in the Pharmaceuticals field. Compared to ICON, Parexel generates $446.1M less revenue.

PPD is one of ICON's top competitors. PPD is headquartered in Wilmington, North Carolina, and was founded in 1985. PPD is in the Biotechnology field. PPD generates 150% the revenue of ICON.

RANK

COMPANY

LEADERSHIP

CEO SCORE

EMPLOYEES

TOTAL FUNDING

REVENUE

Steve Cutler

CEO

- -
12,500
$0
$2.8B
1

Ari Bousbib

Chairman & CEO

66/100
58,000
- -
$11.2B
2

Jamie Macdonald

CEO

83/100
18,600
- -
$2.4B
3

David Simmons

Chairman & CEO

90/100
23,000
$1.6B
$4.3B
4

Adam H. Schechter

President & CEO

74/100
61,000
$1B
$11.6B
5

Colin Shannon

President & CEO

79/100
16,400
$305.6M
$3.1B
6

Alistair Macdonald

CEO

80/100
24,000
- -
$4.7B
7

Paul Kirchgraber

CEO

77/100
61,000
- -
$11.6B
8

James C. Foster

Chairman & CEO

78/100
14,700
$224M
$2.7B
9

August J. Troendle

President & CEO

71/100
2,900
$161M
$891.1M
10

CEO

- -
4,500
- -
$550M
The top 10 competitors in ICON's competitive set are IQVIA, Parexel, PPD, LabCorp, PRA Health Sciences, Syneos Health, Covance, Charles River, Medpace and Chiltern. Together they have raised over 3.3B between their estimated 256.7K employees. ICON has 12,500 employees and is ranked 9th among it's top 10 competitors. The top 10 competitors average 26,963.

Quarterly and Annual Revenue

Coming soon for ICON!

Annual Revenue

$2.8B

ICON's revenue is the ranked 7th among it's top 10 competitors. The top 10 competitors average 5.1B.

Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
MedPass International Limited

Feb 2020

Source »
undisclosed
MedPass provides medical device CRO, regulatory and reimbursement consulting services for pharmaceutical and biotechnology industries.
Symphony Clinical Research

Oct 2019

Source »
undisclosed
Symphony is a provider of in-home and alternate-site clinical trial services.
MeDiNova Limited

May 2019

Source »
undisclosed
MeDiNova is a contract research firm that provides investigator-based clinical research services to the pharmaceutical and biotech industries.
MolecularMD Corp.

Feb 2019

Source »
undisclosed
MolecularMD is a molecular diagnostic laboratory that develops and commercializes oncology precision medicines.
Mapi Group

Jul 2017

Source »
undisclosed
Mapi is a provider of patient centered insights, strategic regulatory and language services for the life science sector.

These are all the companies that ICON has acquired. ICON has acquired 8 companies and its latest acquisition was MedPass International Limited in Feb 2020. MedPass provides medical device CRO, regulatory and reimbursement consulting services for pharmaceutical and biotechnology industries.

ICON Funding History

Since ICON was founded in 1990, it has participated in 1 round of funding. In total ICON has raised $0. ICON's funding round was on Apr 1998 for a total of $0

ROUND

FUNDING DATE

AMOUNT

INVESTORS

IPO
Apr 1998
--
-

Since ICON was founded in 1990, it has participated in 1 round of funding. In total ICON has raised $0. ICON's funding round was on Apr 1998 for a total of $0

Investments

No recent investments found related to ICON

ICON News

May 6, 2020Business & Finance

ICON plc's Q1 figures indicate strong growth

ICON plc has reported revenue of $715.1 million, representing a 6.0% year on year increase or 6.5% on... See more »
April 13, 2020Contract Pharma

ICON Signs New Service Agreement With Pfizer

ICON provides services for Pfizer's clinical trials worldwide... See more »
April 8, 2020MarketScreener

ICON wins multiple categories in 2020 CRO Leadership Awards third year in a row

(marketscreener.com) ICON recognised for specialised services offering across product development lif... See more »
April 5, 2020DirectorsTalk Interviews

ICON plc - Consenus Indicates Potential 30.1% Upside

ICON plc found using ticker (ICLR) now have 14 analysts in total covering the stock. The consensus ra... See more »
March 27, 2020DirectorsTalk Interviews

ICON plc - Consenus Indicates Potential 28.0% Upside

ICON plc with ticker code (ICLR) have now 14 analysts covering the stock with the consensus suggestin... See more »
March 23, 2020DirectorsTalk Interviews

ICON plc - Consenus Indicates Potential 47.1% Upside

ICON plc found using ticker (ICLR) have now 14 analysts covering the stock. The analyst consensus poi... See more »
March 20, 2020DirectorsTalk Interviews

ICON plc - Consenus Indicates Potential 40.5% Upside

ICON plc found using ticker (ICLR) have now 14 analysts in total covering the stock. The consensus ra... See more »

ICON Press Releases

June 9, 2017PR Newswire

Healthcare Stocks on Investors' Radar -- PAREXEL, IDEXX Labs, ICON PLC, and PRA Health Sciences

NEW YORK, June 9, 2017 /PRNewswire/ -- On Thursday, June 08, 2017, US markets saw a mixed session as ... See more »
March 16, 2017Accesswire

Post Earnings Coverage as DexCom's Q4 Top-line Surged 31%; Outshined Forecasts

Upcoming AWS Coverage on ICON Post-Earnings Results LONDON, UK / ACCESSWIRE / March 16, 2017 / Active... See more »
September 22, 2016ReleaseWire

ICON PLC Sponsoring the 4th Annual Brussels Clinical Outsourcing Symposium

The 4th Annual Clinical Outsourcing Strategies and Operations will be held in Brussels on the 20th an... See more »
September 21, 2016ReleaseWire

ICON PLC Exhibiting at Clinical Trial Logistics in Brussels

The 2nd Annual Clinical Trial Supplies Meeting will be held in Brussels on the 20th and 21st of Octob... See more »
September 12, 2016Press Release Rocket

ICON PLC sponsoring the 4th Annual Brussels Clinical Outsourcing Symposium

ICON PLC sponsoring the 4th Annual Brussels Clinical Outsourcing Symposium | Get News Home Business L... See more »
August 3, 2016openPR

Growing number of Contract Research Organizations in Asia to Help Market Growth

Contract research outsourcing (CRO) is one of the emerging trends in the global healthcare industry. ... See more »
July 25, 2016openPR

Growth of Healthcare Contract Research Outsourcing Market Shifts to High Gear with Globalization of Drug Development Processes

A new Transparency Market Research report states that the global healthcare contract research outsour... See more »

ICON Videos

July 10, 2019ICON Youtube Channel

"DOCS: What is meant by Strategic Outsourcing?" on YOUTUBE

See more »
July 10, 2019ICON Youtube Channel

"Meet George McMillan - Current Executive VP & Chief Commercial Officer, ICON plc" on YOUTUBE

See more »
July 10, 2019ICON Youtube Channel

"Meet Quintin Van Wyk - Medical Writing, Regulatory Affairs, ICON plc" on YOUTUBE

See more »
July 10, 2019ICON Youtube Channel

"Meet Martin Clark - Clinical Operations, ICON plc" on YOUTUBE

See more »
June 26, 2019ICON Youtube Channel

"FIRECREST Heart Modelling" on YOUTUBE

See more »
June 26, 2019ICON Youtube Channel

"FIRECREST: Innovation for IMPACT" on YOUTUBE

See more »
June 26, 2019ICON Youtube Channel

"FIRECREST Investigator Portal" on YOUTUBE

See more »

Social Statistics

Headquarters

South County Business Park

Leopardstown, County Dublin

353-1291-2000

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

ICON is a contract research firm that provides outsourced development services to the pharmaceutical, biotechnology and medical device industries. ICON was founded in 1990. ICON's headquarters is located in Leopardstown, County Dublin, IE . It has rai...

CEO

ICON's CEO, Steve Cutler, currently has an approval rating of 72%. ICON's primary competitors are IQVIA, Parexel & PPD.

Website

iconplc.com

Frequently Asked Questions about ICON

  1. When was ICON founded?

    ICON was founded in 1990

  2. Who is ICON's CEO?

    ICON's CEO is Steve Cutler

  3. How much revenue does ICON generate?

    ICON generates $2.8B in revenue

  4. How much funding does ICON have?

    ICON has historically raised $0 in funding

  1. Where is ICON's headquarters?

    ICON's headquarters is in Leopardstown County Dublin, IE

  2. How many employees does ICON have?

    ICON has 12,500 employees

  3. What sector does ICON operate in?

    ICON is in Health Care Services

  4. Who are ICON's competitors?

    ICON's top competitors are IQVIA, Parexel, PPD
Stay up-to-date with the latest news on ICON